September 08, 2023
A federal district judge has thrown out 13 of the remaining lawsuits against dialysis provider Fresenius over claims that two of its products caused heart attacks, finding that even the plaintiffs' own experts could not back up the claims.
November 21, 2017
Attorneys for about a dozen dialysis patients argued in Boston on Tuesday that, although their own experts say otherwise, they should be allowed to seek a jury's opinion on claims that they were gravely injured on the watch of leading kidney clinician Fresenius Medical Care.
August 23, 2017
Fresenius Medical Care's February win in the first bellwether trial in multidistrict litigation alleging its dialysis treatments caused patient deaths proves that 10 more cases should be dismissed, as those cases rely on the same treatment at issue in the bellweather case, the company told a Massachusetts federal court Wednesday.
April 19, 2017
Fresenius Medical Care and a group of patients who say they were injured by the company's dialysis treatments continued to spar over document production in multidistrict litigation in Boston federal court Wednesday.
December 14, 2016
People who want to go to trial on claims that they or their loved ones were injured by Fresenius Medical Care dialysis drugs should have to provide more information about their claims, including expert certifications, a federal judge in Boston said Wednesday.
August 23, 2016
A federal judge in Boston appeared inclined Tuesday to yet again remand Louisiana's case against Fresenius Medical Care Holdings Inc. over the dialysis drugs NaturaLyte and GranuFlo to state court, but left open the question of what to do about the intervention of Blue Cross Blue Shield of Louisiana in the case amid multidistrict litigation.
March 04, 2016
Fresenius Medical Care and plaintiffs with whom they reached a $250 million settlement in principle to end multidistrict litigation over the alleged side effects of the dialysis drugs GranuFlo and NaturaLyte have asked a Massachusetts federal judge to stay proceedings and push back trial dates while they finalize the agreement.
February 17, 2016
Fresenius Medical Care said Wednesday it has reached a $250 million agreement in principle to settle multidistrict litigation over the alleged side effects from dialysis drugs GranuFlo and NaturaLyte, a day after a bellwether trial was scheduled to begin in Massachusetts federal court.
February 10, 2016
Hundreds of Massachusetts and Mississippi cases are eligible to join multidistrict litigation against Fresenius over GranuFlo's and NaturaLyte's alleged side effects, because there was no proof patients or their physicians knew about a 2012 FDA warning about the dialysis drugs, a court was told Wednesday.
February 02, 2016
Fresenius USA Inc. on Tuesday urged a federal judge to throw out hundreds of Massachusetts and Mississippi cases consolidated in multidistrict litigation over alleged side effects from its dialysis drugs GranuFlo and NaturaLyte, saying the claims were filed too late.